Yüklüyor......
Mutations of p53 decrease sensitivity to the anthracycline treatments in bladder cancer cells
Due to doxorubicin (Dox) cardiotoxicity, the next generation of novel non-cardiotoxic anthracyclines, including AD 312 and AD 198, were synthesized and validated. In this study, we assessed the efficacy and mechanisms of anthracyclines-induced apoptosis and inhibition of cell viability in human blad...
Kaydedildi:
| Yayımlandı: | Oncotarget |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Impact Journals LLC
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6033348/ https://ncbi.nlm.nih.gov/pubmed/29983877 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25530 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|